EP
Cisplatin (CDDP) 60 mg/m2 iv d1
Etoposide (VP-16) 120 mg/m2/d iv d1-3
Q3w

Giaccone, G et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1996; 14:814 (link to the article).

PAC
Cisplatin (CDDP) 50 mg/m2 iv d1
Doxorubicin (Adriamycin) 50 mg/m2 iv d1
Cyclophosphamide (Cytoxan) 500 mg/m2 iv d1
Q3w

Loehrer, PJ et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrenc thymoma: final results of an Intergroup trial. J Clin Oncol 1994; 12:1164 (link to the article).

ADOC
Cisplatin (CDDP) 50 mg/m2 iv d1
Doxorubicin (Adriamycin) 40 mg/m2 iv d1
Vincristine 0.6 mg/m2 iv d3
Cyclophosphamide (Cytoxan) 700 mg/m2 iv d4
Q4w

Fornasiero, A et al. Chemotherapy for invasive thymoma. A 13-year experience. Cancer 1991; 68:30 (link to the article).